Lupin Limited Completes Acquisition of VISUfarma B.V.
Lupin Limited announced the completion of its acquisition of VISUfarma B.V., a company based in the Netherlands, effective April 1, 2026. Nanomi B.V., a wholly-owned subsidiary of Lupin, finalized the acquisition after fulfilling customary closing conditions. As a result of this acquisition, VISUfarma B.V. and its wholly-owned subsidiaries are now wholly-owned subsidiaries of Nanomi B.V.Previously, Lupin had disclosed details of the acquisition on September 29, 2025, December 30, 2025, and February 27, 2026, in accordance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.